Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia
TLDR
This case illustrates the risks of treating recently recovered COVID-19 patients with immunosuppressive therapy, particularly lymphocyte- and antibody-depleting therapy, and raises new questions about the potential of SARS-CoV-2 reactivation.Abstract:
SARS-CoV-2 has infected millions of people worldwide, but little is known at this time about second infections or reactivation. Here, we report a case of a 55-year-old female undergoing treatment for CD20+ B cell acute lymphoblastic leukemia who experienced a viral reactivation after receiving rituximab, cytarabine, and dasatinib. She was initially hospitalized with COVID-19 in April and developed a high antibody titer with two negative nasal polymerase chain reaction (PCR) swabs for SARS-CoV-2 on discharge. After recovery, she resumed treatment in June for her leukemia, which included rituximab, cytarabine, and dasatinib. She promptly lost her COVID-19 antibodies, and her nasal PCR turned positive in June. She developed a severe COVID-19 pneumonia with lymphopenia, high inflammatory markers, and characteristic bilateral ground-glass opacities on chest CT, requiring high-flow nasal cannula and transfer to the intensive care unit. She received steroids, anticoagulation, and convalescent plasma, and within 48 h she was off oxygen. She was discharged home in stable condition several days later. Given the short time frame from leukemia treatment to PCR positivity and the low case rate in mid-June in New York City, reinfection appears to have been unlikely and SARS-CoV-2 reactivation is a possible explanation. This case illustrates the risks of treating recently recovered COVID-19 patients with immunosuppressive therapy, particularly lymphocyte- and antibody-depleting therapy, and raises new questions about the potential of SARS-CoV-2 reactivation.read more
Citations
More filters
Journal ArticleDOI
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
TL;DR: In this article, the authors discuss the mechanisms by which RNA viruses beyond just SARS-CoV-2 have been connected to long-term health consequences, and review literature on acute COVID-19 and other virus-initiated chronic syndromes such as post-Ebola syndrome or myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Journal ArticleDOI
COVID-19 and autoimmune diseases.
TL;DR: In this article, the authors evaluated the relationship between infection with SARS-CoV-2 and autoimmunity, focusing on similarities in immune responses, cross-reactivity of SARS and CoV2, the development of autoimmune diseases in COVID-19 patients, and the risk of infection in patients with preexisting autoimmune conditions.
Journal ArticleDOI
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.
Stephen A. Klassen,Jonathon W. Senefeld,Patrick W. Johnson,Rickey E. Carter,Chad C. Wiggins,Shmuel Shoham,Brenda J. Grossman,Jeffrey P. Henderson,James M. Musser,James M. Musser,Eric Salazar,Eric Salazar,William R. Hartman,Nicole M. Bouvier,Sean T. H. Liu,Liise Anne Pirofski,Sarah E. Baker,Noud van Helmond,R. Scott Wright,De Lisa Fairweather,Katelyn A. Bruno,Zhen Wang,Nigel Paneth,Arturo Casadevall,Michael J. Joyner +24 more
TL;DR: In this article, the effect of COVID-19 convalescent plasma on mortality was investigated in hospital patients with COVID19 and showed that early transfusion of higher titer plasma is associated with lower patient mortality.
Journal ArticleDOI
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1.
Zi Yin,Min Yu,Tingting Ma,Chuanzhao Zhang,Shanzhou Huang,Mohammad Reza Karimzadeh,Amir Abaas Momtazi-Borojeni,Sheng Chen +7 more
TL;DR: In this article, the role of exosomal PDL-1 in the therapeutic resistance to anti-PD-1/PD-L1 treatment was reviewed. But, despite impressive treatment outcomes, some patients show poor response to PD-1 and PD-L 1 blockade.
Journal ArticleDOI
Use of convalescent plasma in COVID-19 patients with immunosuppression.
Jonathon W. Senefeld,Stephen A. Klassen,Shane K. Ford,Katherine A. Senese,Chad C. Wiggins,Bruce Bostrom,Michael A. Thompson,Sarah E. Baker,Wayne T. Nicholson,Patrick W. Johnson,Rickey E. Carter,Jeffrey P. Henderson,William R. Hartman,Liise Anne Pirofski,R. Scott Wright,De Lisa Fairweather,Katelyn A. Bruno,Nigel Paneth,Arturo Casadevall,Michael J. Joyner +19 more
TL;DR: In this article, the authors reviewed clinical features and treatment protocols of COVID-19 patients with immunosuppression after treatment with human convalescent plasma and discussed the time course and clinical features of recovery.
References
More filters
Journal ArticleDOI
Virological assessment of hospitalized patients with COVID-2019.
Roman Wölfel,Victor M. Corman,Wolfgang Guggemos,M Seilmaier,Sabine Zange,Marcel A. Müller,Daniela Niemeyer,Terry Jones,Terry Jones,Patrick Vollmar,Camilla Rothe,Michael Hoelscher,Tobias Bleicker,Sebastian Brünink,Julia Schneider,Rosina Ehmann,Katrin Zwirglmaier,Christian Drosten,Clemens M. Wendtner +18 more
TL;DR: Detailed virological analysis of nine cases of coronavirus disease 2019 (COVID-19) provides proof of active replication of the SARS-CoV-2 virus in tissues of the upper respiratory tract.
Journal ArticleDOI
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Nina Le Bert,Anthony T. Tan,Kamini Kunasegaran,Christine Y.L. Tham,Morteza Hafezi,Adeline Chia,Melissa Hui Yen Chng,Meiyin Lin,Meiyin Lin,Nicole Tan,Martin Linster,Wan Ni Chia,Mark I-Cheng Chen,Lin-Fa Wang,Eng Eong Ooi,Shirin Kalimuddin,Paul A. Tambyah,Jenny G. Low,Jenny G. Low,Yee-Joo Tan,Yee-Joo Tan,Antonio Bertoletti,Antonio Bertoletti +22 more
TL;DR: Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Journal ArticleDOI
Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis
TL;DR: A systematic review and meta-analysis showed that lymphopenia on admission was associated with poor outcome in patients with COVID-19 and the association between lymphocyte count and composite poor outcome was affected by age.
Journal ArticleDOI
False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.
TL;DR: It is found that 15 (21.4%) patients experienced a “turn positive” of nucleic acid detection by RT‐PCR test for SARS‐CoV‐2 after two consecutive negative results, which may be related to the false negative of RT‐ PCR test and prolongeducleic acid conversion.
Journal ArticleDOI
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.
Guangming Ye,Zhenyu Pan,Yunbao Pan,Qiaoling Deng,Liangjun Chen,Jin Li,Yirong Li,Xinghuan Wang +7 more
TL;DR: Findings from this small group of cases suggested that there was currently evidence for reactivation of SARS-CoV-2 and there might be no specific clinical characteristics to distinguish them.
Related Papers (5)
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Thomas Hueso,Thomas Hueso,Cécile Pouderoux,Hélène Péré,Anne Lise Beaumont,Laure Anne Raillon,Florence Ader,Lucienne Chatenoud,Deborah Eshagh,Tali Anne Szwebel,Martin Martinot,Fabrice Camou,Etienne Crickx,Marc Michel,Matthieu Mahévas,David Boutboul,David Boutboul,Elie Azoulay,Adrien Joseph,Olivier Hermine,Claire Rouzaud,Stanislas Faguer,Philippe Petua,Fanny Pommeret,Sébastien Clerc,Benjamin Planquette,Fatiha Merabet,Jonathan London,Valérie Zeller,David Ghez,David Veyer,Amani Ouedrani,Pierre Gallian,Jérôme Pacanowski,Arsène Mekinian,Marc Garnier,Pierre Tiberghien,Karine Lacombe +37 more
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?
Marie Gousseff,Pauline Penot,Laure Gallay,Dominique Batisse,Nicolas Benech,Kevin Bouiller,Rocco Collarino,Anne Conrad,Dorsaf Slama,Cédric Joseph,Adrien Lemaignen,François-Xavier Lescure,François-Xavier Lescure,Bruno Levy,Matthieu Mahévas,Bruno Pozzetto,Nicolas Vignier,Benjamin Wyplosz,Dominique Salmon,François Goehringer,Elisabeth Botelho-Nevers +20 more
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.
Kelvin K. W. To,Kelvin K. W. To,Ivan Hung,Jonathan Daniel Ip,Allen Wing-Ho Chu,Wan-Mui Chan,Anthony Raymond Tam,Carol Ho-Yan Fong,Shuofeng Yuan,Hoi-Wah Tsoi,Anthony Chin-Ki Ng,Larry Lap-Yip Lee,Polk Wan,Eugene Yuk-Keung Tso,Wing-Kin To,Dominic N.C. Tsang,Kwok-Hung Chan,Jian-Dong Huang,Kin-Hang Kok,Vincent C.C. Cheng,Vincent C.C. Cheng,Kwok-Yung Yuen,Kwok-Yung Yuen +22 more